Bleomycin, cyclophosphamide and radiotherapy in regionally advanced epidermoid carcinoma of the head and neck |
| |
Authors: | S L Seagren J E Byfield T M Davidson T R Sharp |
| |
Affiliation: | 1. Division of Radiation Oncology, University of California, San Diego, CA, USA;2. Division of Otolaryngology, University of California, San Diego, CA, USA |
| |
Abstract: | We have treated 24 patients with squamous carcinoma of the head and neck and advanced regional (N2-3) disease. The regimen consisted of 3 cycles, each of 28 days. Cyclophosphamide (1 gm/m2 I.V.) was given on day 1, bleomycin (15 u I.M.) on days 2, 4, 9 and 11, and ionizing radiation (60Co, 180 rad/fraction) days 1-5, and 8-12. No therapy was given on days 13-28. After three cycles of therapy, 13 patients had a complete response; following further therapy (surgery, interstitial or external beam radiation), 16 patients were free of disease. However, remissions were not durable and 11/16 patients recurred loco-regionally with a median time to recurrence of 5 months; most (7/11 also developed distant metastases. These patients have biologically aggressive disease and may have a worse prognosis than patients who are Stage IV based on a T4 primary lesion only. |
| |
Keywords: | Bleomycin Cyclopbosphamide Radiation therapy Head and neck cancer |
本文献已被 ScienceDirect 等数据库收录! |
|